Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China

Background: Danhong injection (DHI) accounts for the highest proportion of drug costs for inpatients with coronary heart disease (CHD). However, if DHI price influences utilization remains unclear. Objective: The objective was to compare changes in the use of DHI for CHD patients during three stages...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Liming, Xu, Yue, Su, Zihan, Man, Xiaowei, Jiang, Yan, Zhao, Liying, Cheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114504/
https://www.ncbi.nlm.nih.gov/pubmed/35600876
http://dx.doi.org/10.3389/fphar.2022.857167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114504/
https://www.ncbi.nlm.nih.gov/pubmed/35600876
http://dx.doi.org/10.3389/fphar.2022.857167

Ejemplares similares